Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit

被引:143
作者
Shorr, Andrew F. [1 ]
机构
[1] Washington Hosp Ctr, Dept Pulm & Crit Care Med, Washington, DC 20010 USA
关键词
bacterial drug resistance; costs and cost analysis; Gram-negative bacterial infections; intensive care units; length of stay; mortality; SPECTRUM-BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE BACTEREMIA; VENTILATOR-ASSOCIATED PNEUMONIA; CRITICALLY-ILL PATIENTS; PSEUDOMONAS-AERUGINOSA; RISK-FACTORS; ESCHERICHIA-COLI; NOSOCOMIAL INFECTIONS; MULTIDRUG-RESISTANCE; IMIPENEM RESISTANCE;
D O I
10.1097/CCM.0b013e31819ced02
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective., To review studies addressing mortality, length of stay (LOS), and cost of resistant Gram-negative bacterial infections in the intensive care unit (ICU). Data Sources and Study Selection: A qualitative review of published studies identified through PubMed search was performed. Study exclusion criteria were population <40 adults or <39% of cases in the ICU. Criteria for judging study quality were prospective analysis, multicenter study, author-specified diagnostic criteria, appropriate control group defined as patients with infections caused by susceptible bacteria, adjustments for confounding factors, and use of cost. Data Extraction and Synthesis: Twenty-one original studies and a meta-analysis, which included three of the original studies, were identified. Infections caused by mixed resistant Gram-negative bacteria, extended-spectrum beta-lactamase-producing Enterobacteriaceae, multidrug-resistant Pseudomonas aeruginosa, and Acinetobacter species were generally associated with Increased mortality and LOS, especially in univariate analyses. Economic analyses performed in eight studies indicated that these resistant Gram-negative infections were also associated with increased patient charges or hospital costs. Associations sometimes disappeared in multivariate analyses after adjusting for variables significant in univariate analyses. Conclusion. The collective findings of the studies in this review suggested that Gram-negative bacterial resistance increases the burden in the ICU as measured by mortality, LOS, and charges. More prospective studies are needed to explore methods for combating Gram-negative resistance, including prevention, education, and better antimicrobial therapy. For example, well-designed research is needed to determine the cost-effectiveness of appropriate empiric therapy with broad-spectrum agents active against resistant Gram-negative bacteria followed by de-escalation. (Crit Care Med 2009; 37:1463-1469)
引用
收藏
页码:1463 / 1469
页数:7
相关论文
共 32 条
[1]   Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact [J].
Aloush, V ;
Navon-Venezia, S ;
Seigman-Igra, Y ;
Cabili, S ;
Carmeli, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :43-48
[2]   Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods:: report from the SENTRY Antimicrobial Surveillance Program [J].
Bhavnani, SM ;
Ambrose, PG ;
Craig, WA ;
Dudley, MN ;
Jones, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 54 (03) :231-236
[3]   An outbreak of multidrug-resistant Pseudomonas aeruginosa associated with increased risk of patient death in an intensive care unit [J].
Bukholm, G ;
Tannæs, T ;
Kjelsberg, ABB ;
Smith-Erichsen, N .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2002, 23 (08) :441-446
[4]   Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections [J].
Cao, B ;
Wang, H ;
Sun, H ;
Zhu, Y ;
Chen, M .
JOURNAL OF HOSPITAL INFECTION, 2004, 57 (02) :112-118
[5]   Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia [J].
Combes, Alain ;
Luyt, Charles-Edouard ;
Fagon, Jean-Yves ;
Wolff, Michel ;
Trouillet, Jean-Louis ;
Chastre, Jean .
INTENSIVE CARE MEDICINE, 2006, 32 (12) :1970-1978
[6]   Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species [J].
Cosgrove, SE ;
Kaye, KS ;
Eliopoulous, GM ;
Carmeli, Y .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (02) :185-190
[7]   Cost of Gram-negative resistance [J].
Evans, Heather L. ;
Lefrak, Shayna N. ;
Lyman, Jason ;
Smith, Robert L. ;
Chong, Tae W. ;
McElearney, Shannon T. ;
Schulman, Alison R. ;
Hughes, Michael G. ;
Raymond, Daniel P. ;
Pruett, Timothy L. ;
Sawyer, Robert G. .
CRITICAL CARE MEDICINE, 2007, 35 (01) :89-95
[8]  
Garcia Joseani Coelho Pascual, 2007, J. bras. pneumol., V33, P175, DOI 10.1590/S1806-37132007000200012
[9]   Risk factors for and impact of infection or colonization with aztreonam-resistant Pseudomonas aeruginosa [J].
Gasink, Leanne B. ;
Fishman, Neil O. ;
Nachamkin, Irving ;
Bilker, Warren B. ;
Lautenbach, Ebbing .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (10) :1175-1180
[10]   Fluoroquinolone-resistant Pseudomonas aeruginosa:: Assessment of risk factors and clinical impact [J].
Gasink, Leanne B. ;
Fishman, Neil O. ;
Weiner, Mark G. ;
Nachamkin, Irving ;
Bilker, Warren B. ;
Lautenbach, Ebbing .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (06) :526.e19-526.e25